JPND held an industry consultation meeting on May 16th, 2011 at the University of Milan, Italy.

The consultation brought together representatives from biotechnology, biopharmaceutical and diagnostic companies with specific interest in the neurodegenerative diseases that fall within the focus of the JPND research agenda.

The aim of the meeting was to ascertain; the key priorities and needs of industries active in the field of ND, the “industry view” on the priorities identified by the academic sector through the thematic workshops, and the specific requirements for collaborative activity with the academic sector and other stakeholders (funders, regulators, etc.).

Download the summary report on the meeting findings here.

Chairperson: Adriana Maggi, MIUR, Italy

Presentations: Click on the presentation title to download the slides (pdf)

1. Introduction to JPND – Adriana Maggi

2. Developing the SRA – Catherine Moody

3. Outcomes of the Thematic Workshops – Adriana Maggi

Participants

Mohammad S. Alavijeh Managing Director Pharmidex Pharmaceutical Ltd UK
Mariangela Amoroso Neuroscience and Immunoscience Area Head Bristol Meyer Squibb
John R. Atack Senior Fellow, In Vitro Neuroscience Janssen R&D, J&J Pharmaceutical
Roberta Buti Grant Manager Chiesi Farmaceutici
Stefano Bruni Scientific Director Genzyme
Carla Caccia Grant Manager Newron Pharmaceuticals SpA
Donatella Crippa Head of Medical Affairs Bayer Healthcare
Milva D’Aronco Country Leader, Alzheimer’s Disease Pfizer, Italy
Daniele D’Ilario Medical & Scientific Relations CNS & Pain Pfizer, Italy
Béatrice David Latin Europe Sales Manager Caliper Life Science
Grazia Dell’Agnello Medical Advisor Lilly, Italy
Koen Dewaele Alzheimer’s Programme Director Innogenetics NV
Sophie Dix Senior Research Scientist, ND Drug Hunting Team Lilly, UK
Bruno Imbimbo Head, CNS Research Chiesi Farmaceutici
Rainer Kuhn Head of Neurodegeneration Research Novartis Pharma AG
Wally Landsberg European Medical Lead, Neuroscience Bristol Meyer Squibb
Bertrand Loubaton Director, Pharmaceutical & Academic Research Collaboration Academic Programs GE HealthCare
Fabio Maggioni Diagnostic Imaging Medical Science Liaison Bayer Healthcare
Gareth Maher-Edwards Director, Clinical Development GlaxoSmithKline
Francesco Moneta Lead, Molecular Resonance Imaging Bruker, Italy
Pierangelo Morini Deputy Administrator Bruker, Italy
Francois Nicolas BioSignature Technology Leader GE HealthCare
Michael O’Neill Senior Research Advisor, ND Drug Hunting Team Lilly, UK
Jan Torleif Pedersen Section head, Bioinformatics H. Lundbeck A/S
Thomas Rooney Ageing Therapeutic Strategic Unit, Head Translational Research Group Sanofi-Aventis
Patricia Salvati VP Preclinical Research and Development Newron Pharmaceuticals SpA
Erik Wong Director, External Science CNS Pain Innovative Medicine Unit AstraZeneca Pharmaceuticals LP
Sean Greatbanks JPND Programme Administrator MRC (UK)
Adriana Maggi JPND Executive Board Vice-Chair and Director, Centre of Excellence on NDD’s, Milan MIUR (Italy)
Catherine Moody JPND Manager & Neurosciences and Mental Health Programme Manager MRC (UK)
Micol Zappa JPND Programme Manager MIUR (Italy)